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Abstract
Background: Injection drug users continue to be at high risk of HIV and HCV. Research has shown that needle 
exchange programs (NEP) decrease injection frequency, reduce syringe reuse, and reduce needle sharing, though 
some results have been mixed.
Methods: This evaluation of a small, peri-urban, legal NEP near Ypsilanti, Michigan describes the operation of the NEP 
and its clients. It uses interviews conducted with NEP participants between 2003 and 2006, describing the population 
served by the program, and draws on limited comparisons between matched baseline and follow-up measures as well 
as aggregate baseline and follow-up comparisons.
Results: The HIV/AIDS Resource Center (HARC) Harm Reduction NEP serves a diverse population from a wide 
geographical area. NEP participants at follow-up reused their syringes significantly fewer times before getting new 
ones, were significantly less likely to report giving another IDU a previously used syringe, and were more likely to clean 
their skin with alcohol either before or after injecting than the baseline comparison group.
Conclusions: The limited data presented here suggest that a NEP can be an effective method of harm reduction even 
in low-volume, non-urban settings and are an important venue for intervention in peri-urban areas.
Background
As of 2001 in the United States, approximately one-third
of AIDS cases and one-half of new hepatitis C cases were
associated with injection drug use (IDU) [1]. In 2006,
injection drug use was a risk factor in approximately 16%
of new HIV cases. Although new infections among IDUs
declined in the past decade, IDUs remain a high risk pop-
ulation. IDUs and their sex partners represent approxi-
mately one-third of persons infected in the HIV epidemic
and continue to be at risk for transmitting both HIV and
HCV, necessitating continued prevention efforts [2].
These data highlight the significant problem of HIV risk
and infection among IDUs in the United States.
In 1986, the first NEP in this country began in New
Haven, CT [3]. Since then, and despite a ban on federal
funding for NEPs that ended in late 2009, the number of
NEPs and evidence of their effectiveness has grown sig-
nificantly [4]. NEPs have been associated with substan-
tially decreased odds of HIV risk behavior [5]. Research
shows NEPs decrease injection frequency, reduce syringe
reuse, and reduce needle sharing, though some results
have been mixed [6-10]. In addition to reduction of injec-
tion risk, NEPs may be a valuable venue for sexual risk
reduction interventions.
Although opponents of NEPs cite drug treatment as an
alternative to harm reduction, there is some evidence that
former needle exchange-using IDUs were more likely
than never-exchangers to remain in drug treatment [7].
Evidence is mixed, however, and additional research is
necessary to determine how best to promote access to
drug treatment for NEP participants [11].
The focus of current research and evaluation has been
on large urban NEPs such as those in New York City, New
York, Baltimore, Maryland, and New Haven, Connecti-
cut. While these programs represent a large percentage of
syringes exchanged, there remains a gap in the literature.
We hypothesize that even smaller programs in peri-urban
cities will reduce HIV risk behaviors and show many of
the same benefits demonstrated in larger programs.
The HIV/AIDS Resource Center (HARC) in Ypsilanti,
Michigan runs a legal NEP in several surrounding cities
and townships. HARC operates under the principles of
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harm reduction, acknowledging that individuals will con-
tinue to use substances until they determine a need or
develop a willingness to change. HARC provides sterile
syringes, safer injection materials, condoms, HIV testing
and counseling, as well as a substance abuse specialist to
coordinate entry into treatment programs in order to
enable individuals to access evidence-based behavioral
intervention alternatives without judgment or moraliza-
tion. The HARC program serves individuals from a four-
country region comprised mainly of small cities and
townships, as well as some clients from more rural areas.
This evaluation was conducted to determine whether a
small NEP, a proven harm reduction program, would
demonstrate behavioral risk reduction effects in a peri-
urban area.
Methods
During the summer of 2006, the first author spent several
days each week as a volunteer with the HARC NEP. The
description of the operation of the program is based on
her impressions and discussions with HARC staff.
Between 2003 and 2006, HARC NEP staff interviewed
needle exchange participants at their first visit and again
at 6-months using an intake and follow-up questionnaire
designed by HARC. Interviews were conducted in a pri-
vate room in the HARC outreach van to maintain privacy
and confidentiality. A structured survey form was
employed to gather information from NEP clients.
The forms were altered slightly over time to increase
the accuracy of the interview responses and to more pre-
cisely reflect the NEP goals. In total there were five ques-
tionnaire versions. Responses to items on each version of
the questionnaire were coded to combine identical ques-
tions. Identical questions that appeared on some versions
with a numerical frequency scale (i.e., none, 1-3 times, 4-
6 times, 7-9 times, 10+ times) and on other versions with
a subjective response scale (i.e., never, rarely, sometimes,
often, always) were also combined.
Variables representing frequency of using a previously
used needle, giving used syringes to another IDU,
exchanging needles for another IDU, sharing other injec-
t i o n  m a t e r i a l s ,  c l e a n i n g  s k i n  w i t h  a l c o h o l ,  r e u s i n g  t h e
same syringe, bleaching needles before reuse, condom
usage, and HIV testing were dichotomized into "never"
(included "zero" and "never" responses) or "ever"
(included responses indicating they had previously been
tested, previously received results, or had consented to
being tested at the time of the interview) to reflect the
potential for measurement differences based on the
scales used in different versions of the questionnaires. A
dichotomized item to represent the number of sexual
partners reported was also created: either one partner or
any number greater than one (those NEP users with no
sexual partners were excluded from the analysis of this
variable).
HARC used the Transtheoretical Model to measure
progress toward changing drug-using behaviors [12].
Individual respondent's stage was measured using a sin-
gle question regardless of the questionnaire version
employed. Some versions explicitly stated the five stages
(Pre-contemplation, Contemplation, Preparation, Action,
or Maintenance) and asked respondents to pick the stage
that best described them. Other versions used a proxy
measure and asked respondents to select from a list of
statements the one that best described them in order to
represent the client's stage (i.e., not at risk, need to
decrease risk, ready to change, started doing things, or
have been doing things). Responses to all forms of this
question were combined into a single scale and coded as
follows: 1 = Pre-contemplation or Not at risk, 2 = Con-
templation or Need to decrease risk, 3 = Preparation or
Ready to change, 4 = Action or Started doing things, and
5 = Maintenance or Have been doing things.
The initial data analysis plan consisted of paired com-
parisons between baseline and follow-up measurements
of injection-related and sexual behavior-related HIV risk
behaviors. Descriptive analyses revealed that only a small
number of subjects completed both baseline and follow-
up interviews which changed the analysis plan signifi-
cantly. As a result, the focus of the analysis was shifted to
a description of the program and the population it serves.
Aggregated baseline interviews were compared with
aggregated follow-up interviews using the dichotomized
variables to examine general trends over time. Although
there was potentially a correlation between the observa-
tions of the 14 individuals with both baseline and follow-
up interviews, and a generalized estimating equation
model was considered, independence was assumed
because the correlated observations were only a small
percentage of the total number of observations. Logistic
regression was used to calculate unadjusted odds ratios
for the dichotomized variables using baseline measure-
ment as the reference category, and simple linear regres-
sion was used to calculate coefficients, confidence
intervals, and p-values for continuous and ordinal cate-
gorical variables. The logistic regression models initially
included only the baseline/follow-up variable as a predic-
tor. Race and sex, when added to the model, were not sig-
nificant and not retained in further models. Odds ratios
were calculated for the follow-up group compared to the
baseline group. The small paired sample was analyzed
using paired t-tests on non-dichotomized variables
(except for whether the individual had ever had an HIV
test, which was dichotomized into never or ever) to assess
differences between the two groups and to generate
hypotheses for further investigation. SPSS and R statisti-
cal packages were used for statistical analysis.Knittel et al. Harm Reduction Journal 2010, 7:8
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This study was approved by the Medical School Institu-
tional Review Board (IRBMED - HUM00004528) and
reapproved by the Health Sciences and Behavioral Sci-
ences IRB at the University of Michigan after a change in
university affiliation.
Results
Description of the NEP
The HARC NEP was started in December of 2000 and is
run exclusively from the outreach van that parks three
days a week in designated locations to provide easy access
for injection drug users. The NEP provides a wide range
of services, including HIV testing, safer sex materials,
bleach kits, hygiene kits, risk reduction counseling and
referrals to needed services including substance abuse
treatment. The actual exchange of used syringes for clean
ones occurs in a private part of the van not visible to
other clients approaching the van to obtain condoms,
other safer sex materials, or information from the volun-
teers and staff. This private space is also used for HIV
counseling and testing, in-depth risk reduction counsel-
ing, and sometimes testing for hepatitis C provided by the
health department.
Availability of the needle exchange program at outreach
van sites has varied over time due to local politics and
jurisdiction boundaries. Although several sites have con-
sistently allowed legal needle exchange, many of the small
townships have decided in recent years that needle
exchange is unnecessary in their communities - often
independent of any data on injection drug use in those
same communities. Due to privacy and legal concerns,
participants in the NEP are rarely willing to speak at com-
munity meetings about their need for needle exchange,
making evidence-based policy-making difficult. The
dearth of anecdotal and experiential information is fur-
ther compounded by a lack of quantitative data for many
of the same reasons. Also complicating the operation of
the NEP is its coverage of a wide array of jurisdictions,
including several cities and townships that each requires
their own permissions and approvals.
In spite of these difficulties, many NEP clients are long-
time users of the program, following it from site to site,
and have developed relationships with the NEP staff. The
ability of the NEP staff to maintain confidentiality as well
as rapport with the clients is an asset to the program and
allows for continuity even in the face of political vulnera-
bility.
Description of the NEP Participants
Table 1 presents the response rates for NEP participants.
Eighty-eight individuals were surveyed at baseline and
these included all unique ID numbers for respondents
between 2003 and 2006. Of these, 74 (84%) completed
only a baseline interview while 14 individuals (16%) com-
pleted both a baseline and follow-up interview. A total of
31 individuals completed follow-up interviews. Of these,
17 respondents (55%) completed a follow-up interview
having utilized NEP services for a time without first com-
pleting a baseline interview.
Table 2 gives a demographic description of the NEP
participants. The participants were primarily male (78.6%
and 52.9% male at baseline and follow-up respectively),
though the proportion of female participants at follow-up
was appreciably higher. The median age was approxi-
mately 50 years old, with an inter-quartile range of 43-56
years in the baseline only group, 44-52 in the follow-up
only group, and 49-56 among those participants who
completed both a baseline and follow-up interview.
Slightly more than half of the population served by the
NEP is Black or African American, though there is a high
rate of unreported race/ethnicity measures, so this should
only be considered an estimate.
Participants in the NEP live primarily in zip codes
48197 and 48198, closest in proximity to the NEP sites.
These two zip codes correspond with the city of Ypsilanti,
with 22,362 residents, as well as the townships and vil-
lages further out from the city center [13]. Ypsilanti is
located approximately 12 miles east of Ann Arbor (itself a
city of approximately 114,000), and 35 miles west of
Detroit. The other zip codes given by NEP participants
show that HARC provides services to individuals coming
from many parts of Washtenaw county (8 zip codes), six
zip codes in Wayne county, including several participants
from Detroit, and potentially part of Livingston county
(one zip code overlaps Washtenaw and Livingston coun-
ties), though most of these individuals completed only
baseline measures. Follow-up questionnaires come from
a much more limited geographical area (the two Ypsilanti
zip codes plus one immediately adjacent in Wayne
county), and those individuals who completed both a
baseline and follow-up questionnaire lived exclusively in
the two Ypsilanti zip codes.
Comparison of Participants at Baseline and Follow-up
Due to the small number of interviews completed and the
high degree of missing data as shown in Tables 1 and 2,
sex and race were neither significant predictors of being
in the follow-up group rather than being in the baseline
group nor significant predictors of any of the dependent
variables tested (e.g., injection frequency, sharing injec-
tion materials, condom usage, etc.). The estimated effect
of being female was large, with female respondents hav-
ing two times the odds of male respondents of being in
the follow-up group, but the confidence interval was also
substantial (0.80 - 4.86). Measurement of the effect of
race was impossible due to the lack of data on follow-up
participants.Knittel et al. Harm Reduction Journal 2010, 7:8
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Using the aggregated groups of baseline and follow-up
respondents to calculate unadjusted odds ratios of engag-
ing in injection-related or sexual behavior-related HIV
risk behaviors showed two statistically significant find-
ings. First, compared to the baseline group, individuals at
follow-up were significantly less likely to report giving
another IDU a previously used syringe (OR = 0.38, p =
0.042). Second, follow-up participants were more likely to
clean their skin with alcohol either before or after inject-
ing than the baseline comparison group (OR = 3.71, p =
0.01).
Other measures of injection-related risk behavior
showed non-significant trends in the direction of risk
reduction from baseline to follow-up. NEP users at fol-
low-up were less likely to report sharing syringes (OR =
0.66), sharing equipment other than syringes (OR = 0.70),
or reusing syringes (OR = 0.34). Follow-up users were
also more likely to report exchanging syringes for another
individual (OR = 2.77), though this also failed to reach
statistical significance. The odds ratio for using bleach to
clean needles and works before reusing them was approx-
imately zero, though there were very low rates of reported
bleach use in both the baseline and follow-up groups.
Uptake of other NEP services (e.g., referral into treat-
ment and sexual risk reduction counseling) showed
mixed, not statistically significant differences. Positive
trends included evidence that participants in the follow-
up group were more likely to be willing to go to drug
treatment (OR = 1.84) and less likely to report having
more than one sexual partner (OR = 0.42). The follow-up
group was also less likely to report using a condom (OR =
0.76), though this was not significant.
Self-reported willingness to change injection-related
HIV risk behavior (i.e., Stages of Change) was analyzed
using a simple regression analysis. On average, respon-
dents reported an increase of 0.24 stages from baseline to
follow-up, though this increase was not statistically sig-
nificant. Using a logistic regression model to calculate the
unadjusted odds ratio, follow-up participants were 1.55
times more likely to be in a stage other than pre-contem-
plation than baseline participants, though this was also
not statistically significant.
As shown in Table 1, there were very few participants
who completed both a baseline and follow-up question-
naire. Due to this extremely limited sample size, findings
from these data should be taken as suggestive of larger
trends. Compared to baseline measurements, NEP par-
ticipants reused their syringes significantly fewer times
before getting new ones (p = 0.012). No other compari-
sons reached statistical significance. There were also
modest, but not significant, increases in the number of
i n d i v i d u a l s  w h o  r e p o r t e d  e v e r  h a v i n g  b e e n  t e s t e d  f o r
HIV, as well as increases in the number of individuals
who reported cleaning their skin either before or after
injecting. There was also a very small decrease in the
number of partners reported and a decrease in reported
condom use, though both failed to achieve statistical sig-
nificance. The data also suggest that participants at both
time points are heavy injection drug users averaging
more than one injection per day.
Discussion
The HARC NEP is a relatively small program that fills a
critical but often unrecognized need in the community.
The HARC Harm Reduction website states that: "Many
people think injection drug use (IDU) is not a problem
where we live. However, just under 25% of the AIDS cases
in HARC's region can be attributed to IDU. It is estimated
Table 1: Response rates
n%
Overall baseline sample 88 (100)
Baseline only 74 (84)
Overall follow-up sample 31 (100)
Follow-up only 17 (55)
Baseline and follow-up 14 (16)Knittel et al. Harm Reduction Journal 2010, 7:8
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that between 60% to 80% of all IDU (injecting drug users)
are Hepatitis C positive [14]." Though systematic data
collection is difficult within small non-profit organiza-
tions, analysis of the effectiveness of this type of program
is important.
The data presented here suggest that a NEP can be an
effective method of harm reduction even in low-volume
non-urban settings. While many of the findings were not
statistically significant given the small sample size and
relatively poor data quality, the consistently positive
trends in support of NEP in this setting are suggestive of
meaningful behavior change. The results suggest that
NEP participation may decrease some injection risk
behaviors for HIV including using syringes previously
used by another IDU, giving used syringes to other IDUs,
and sharing injection equipment other than syringes.
That the frequency of injection does not seem to change
significantly from baseline to follow-up suggests that
individuals using NEP programs are not yet ready to
enter treatment and substantially change their drug use
Table 2: Demographic description of study sample
Baseline Only Follow-Up Only Both
Total sample size 74 17 14
% male 78.3 52.9 78.6
Age in 2006 (years) (years) (years)
Mean (SD) 48 (12) 47 (9) 54 (8)
1st Quartile 56 52 56
Median 51 48 52
3rd Quartile 43 44 49
Race/Ethnicity N (%) N (%) N (%)
Black/African American 40 (54.0) 2 (11.8) 8 (57.1)
White/Caucasian 32 (43.0) 0 (0) 5 (35.7)
Native American/Alaskan
Native
2 (2.7) 0 (0) 0 (0)
Not recorded 0 (0) 15 (88.2) 1 (7.1)
% zip 48197/8 71.6 87.5 100Knittel et al. Harm Reduction Journal 2010, 7:8
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behaviors. This finding reinforces the importance of pro-
viding harm reduction materials and resources to this
population. It is notable that individuals who may enter
treatment (and stop using the NEP) are not captured in
any of the follow-up measures, so the preliminary results
documented here should be interpreted with the under-
standing that those individuals who have benefited most
from this harm reduction intervention are not included
in the follow-up sample.
In addition to clean needles, the NEP provides other
injection-related harm reduction materials and resources
such as cotton, cookers, bleach, and alcohol to clean the
skin. In this sample, NEP participation increased the use
of alcohol to clean skin when injecting drugs and this
increase was statistically significant. Provision of these
other resources is an important infection-control mecha-
nism, and is suggestive of a positive effect of NEP partici-
pation on injection site infections.
NEP participants were encouraged to reduce sexual risk
as well as injection risk of HIV through pre- and post-test
counseling and casual interactions with outreach van
staff. Only two participants at follow-up reported not
having had an HIV test and, although there was missing
data from the baseline group (30 individuals did not
report whether they had had an HIV test previously), all
those who answered the question responded that they
had been tested. This finding reinforces previous work
suggesting that NEP users are often the highest risk injec-
tion drug users, and indicates that the NEP is doing an
excellent job promoting HIV testing among those users
who had not been tested prior to entering the program.
The observed decrease in condom use between base-
line and follow-up is potentially disturbing, as NEPs often
emphasize safer sex behaviors as well as safer injection
behaviors. The statistically insignificant decrease in con-
dom use may be explained by the decrease in the number
of partners; the limited sample size should also temper
interpretation of this finding. Nonetheless, this finding
may warrant more specific evaluation of sexual risk
behavior outcomes of this NEP and indicate that a stron-
ger emphasis is needed on safer sex practices among
IDUs, even among those in monogamous relationships, if
their needle sharing practices put themselves or their
partners at risk.
There are significant limitations to this evaluation.
Multiple questionnaire versions make comparisons diffi-
cult. Both the matched and aggregate comparisons likely
underestimate the program's effect. As was noted earlier,
those individuals who entered treatment and stopped
using drugs were not captured at follow-up, diminishing
the observed effect of the program. A more powerful
study with a larger sample size would likely have shown
that non-significant differences in injection-related risk
behavior in the present study do, in fact, represent sub-
stantial behavior change. The aggregate comparisons also
likely underestimate the effect of the program because
the variables were dichotomized. If the data had been col-
lected consistently with an ordinal scale, it would have
been possible to use the full range of data reported.
Instead, information was lost when the categories were
collapsed into "never" and "ever," though this was neces-
sary since not all respondents answered using the same
scales. In addition, the small sample size is likely a result
of not only observing a particularly transient population,
but also a focus on the part of HARC staff on the provi-
sion of services and not necessarily evaluation. Given
their limited time and resources, this allocation makes
sense. In spite of these limitations, these data provide
important and unique evaluation outcomes from a peri-
urban NEP. For this reason, these findings are an impor-
tant contribution to the literature evaluating the effec-
tiveness of needle exchange programs.
Conclusions
Overall and despite the limitations, this evaluation shows
the promise of small-scale needle exchange programs in
areas not served by large urban needle exchange pro-
grams. Even using very small samples and dichotomized
measures, this evaluation showed that a small peri-urban
needle exchange program can contribute to reducing
injection-related HIV risk behavior.
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